Anne D. Villela

Av. Ipiranga 6681 Prédio 92A Tecnopuc
Porto Alegre, RS 90619900, Brazil

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 25 publications

Anti-tubercular profile of new selenium-menadione conjugates against Mycobacterium tuberculosis H37Rv (ATCC 27294) strain and multidrug-resistant clinical isolates.

Anti-tubercular profile of new selenium-menadione conjugates against Mycobacterium tuberculosis H37Rv (ATCC 27294) strain and multidrug-resistant clinical isolates.

Journal: European journal of medicinal chemistry

Published: June 08, 2020

Advancing Immunotherapeutic Vaccine Strategies Against Pulmonary Tuberculosis.

Advancing Immunotherapeutic Vaccine Strategies Against Pulmonary Tuberculosis.

Journal: Frontiers in immunology

Published: April 30, 2020

Nonclinical evaluation of IQG-607, an anti-tuberculosis candidate with potential use in combination drug therapy.

Nonclinical evaluation of IQG-607, an anti-tuberculosis candidate with potential use in combination drug therapy.

Journal: Regulatory toxicology and pharmacology : RTP

Published: July 20, 2019

Pre-clinical evaluation of quinoxaline-derived chalcones in tuberculosis.

Pre-clinical evaluation of quinoxaline-derived chalcones in tuberculosis.

Journal: PloS one

Published: May 10, 2018

Is IQG-607 a Potential Metallodrug or Metallopro-Drug With a Defined Molecular Target in Mycobacterium tuberculosis?

Is IQG-607 a Potential Metallodrug or Metallopro-Drug With a Defined Molecular Target in Mycobacterium tuberculosis?

Journal: Frontiers in microbiology

Published: February 15, 2018

1H-Benzo[d]imidazoles and 3,4-dihydroquinazolin-4-ones: Design, synthesis and antitubercular activity.

1H-Benzo[d]imidazoles and 3,4-dihydroquinazolin-4-ones: Design, synthesis and antitubercular activity.

Journal: European journal of medicinal chemistry

Published: January 10, 2018

Assessing the role of deoD gene in Mycobacterium tuberculosis in vitro growth and macrophage infection.

Assessing the role of deoD gene in Mycobacterium tuberculosis in vitro growth and macrophage infection.

Journal: Microbial pathogenesis

Published: November 29, 2017

Revisiting Activation of and Mechanism of Resistance to Compound IQG-607 in Mycobacterium tuberculosis.

Revisiting Activation of and Mechanism of Resistance to Compound IQG-607 in Mycobacterium tuberculosis.

Journal: Antimicrobial agents and chemotherapy

Published: October 30, 2017

Synthesis and mechanistic investigation of iron(II) complexes of isoniazid and derivatives as a redox-mediated activation strategy for anti-tuberculosis therapy.

Synthesis and mechanistic investigation of iron(II) complexes of isoniazid and derivatives as a redox-mediated activation strategy for anti-tuberculosis therapy.

Journal: Journal of inorganic biochemistry

Published: July 17, 2017

Effect of the bradykinin 1 receptor antagonist SSR240612 after oral administration in Mycobacterium tuberculosis-infected mice.

Effect of the bradykinin 1 receptor antagonist SSR240612 after oral administration in Mycobacterium tuberculosis-infected mice.

Journal: Tuberculosis (Edinburgh, Scotland)

Published: May 22, 2017

Construction of Mycobacterium tuberculosis cdd knockout and evaluation of invasion and growth in macrophages.

Construction of Mycobacterium tuberculosis cdd knockout and evaluation of invasion and growth in macrophages.

Journal: Memorias do Instituto Oswaldo Cruz

Published: March 15, 2017

Activity of 2-(quinolin-4-yloxy)acetamides in Mycobacterium tuberculosis clinical isolates and identification of their molecular target by whole-genome sequencing.

Activity of 2-(quinolin-4-yloxy)acetamides in Mycobacterium tuberculosis clinical isolates and identification of their molecular target by whole-genome sequencing.

Journal: International journal of antimicrobial agents

Published: March 13, 2017

Showing 1-12 of 25

Last Updated: 09/26/2026